Advances in Cancer Research
Genomics in Cancer Drug Discovery and Development
- 1 Edición, Volumen 96 - 15 de diciembre de 2006
- Última edición
- Editores: George F. Vande Woude, Garret Hampton, Karol Sikora, George Klein
- Idioma: Inglés
The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume stands as the first ever themat… Leer más
Descripción
Descripción
The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume stands as the first ever thematic volume in the series, focusing on the topic of genomics in cancer drug development. The chapters included in this book represent the cutting-edge information in the field and span such topics as Mass Spectrometry: Uncovering the Cancer Proteome for Diagnostics; Biomarker Discovery in Epithelial Ovarian Cancer by Genomic Approaches; The Application of siRNA Technology to Cancer Biology Discovery; Ribozyme Technology for Cancer Gene Target Identification and Validation; Cancer Cell-Based Genomic and Small Molecule Screens; Tumour Antigens as Surrogate Markers and Targets for Therapy and Vaccines; Practices and Pitfalls of Mouse Cancer Models in Drug Discovery; Biomarker Assay Translation from Discovery to Clinical Studies in Cancer Drug Development – Quantification of Emerging Protein Biomarkers; Molecular Optical Imaging of Therapeutic Targets of Cancer; Cancer Drug Approval in the United States, Europe and Japan.
De interès para
De interès para
Researchers and students in the basic and clinical science of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology and molecular biology.
Índice
Índice
Mass Spectrometry: Uncovering the Cancer Proteome for Diagnostics.
Biomarker Discovery in Epithelial Ovarian Cancer by Genomic Approaches.
The Application of siRNA Technology to Cancer Biology Discovery.
Ribozyme Technology for Cancer Gene Target Identification and Validation.
Cancer Cell-Based Genomic and Small Molecule Screens.
Tumour Antigens as Surrogate Markers and Targets for Therapy and Vaccines.
Practices and Pitfalls of Mouse Cancer Models in Drug Discovery.
Biomarker Assay Translation from Discovery to Clinical Studies in Cancer Drug Development – Quantification of Emerging Protein Biomarkers.
Molecular Optical Imaging of Therapeutic Targets of Cancer.
Cancer Drug Approval in the United States, Europe and Japan.
Biomarker Discovery in Epithelial Ovarian Cancer by Genomic Approaches.
The Application of siRNA Technology to Cancer Biology Discovery.
Ribozyme Technology for Cancer Gene Target Identification and Validation.
Cancer Cell-Based Genomic and Small Molecule Screens.
Tumour Antigens as Surrogate Markers and Targets for Therapy and Vaccines.
Practices and Pitfalls of Mouse Cancer Models in Drug Discovery.
Biomarker Assay Translation from Discovery to Clinical Studies in Cancer Drug Development – Quantification of Emerging Protein Biomarkers.
Molecular Optical Imaging of Therapeutic Targets of Cancer.
Cancer Drug Approval in the United States, Europe and Japan.
Detalles del producto
Detalles del producto
- Edición: 1
- Última edición
- Volumen: 96
- Publicado: 15 de diciembre de 2006
- Idioma: Inglés
Sobre los editores
Sobre los editores
GV
George F. Vande Woude
Afiliaciones y experiencia
Director, Van Andel Research Institute, Grand Rapids, MI, USA
NCI-Frederick Cancer Research Facility Frederick, Maryland
ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, MarylandGH
Garret Hampton
Afiliaciones y experiencia
Celgene Signal Research, San Diego, CA, U.S.A.KS
Karol Sikora
Afiliaciones y experiencia
Professor, Hammersmith Hospital, Hammersmith, U.K.GK
George Klein
Afiliaciones y experiencia
Karolinska Insitutet, Stockholm, SwedenVer libro en ScienceDirect
Ver libro en ScienceDirect
Lee Advances in Cancer Research en ScienceDirect